Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» NxStage® Announces the Sale of 3.2 Million Shares of Common Stock
NxStage® Announces the Sale of 3.2 Million Shares of Common Stock
NxStage® Announces the Sale of 3.2 Million Shares of Common Stock
Submitted by
moderatora
on November 18, 2010 - 10:48am
Source:
PRNewswire
News Tags:
NxStage
stocks
ESRD
acute kidney failure
Headline:
NxStage® Announces the Sale of 3.2 Million Shares of Common Stock
Do Not Allow Advertisers to Use My Personal information
